Related Experiment Videos
Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and
N J Meropol1, L L Miller, E L Korn
1Hematology-Oncology Section, Hospital of the University of Pennsylvania, Philadelphia.
Journal of the National Cancer Institute
|August 5, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Interim monitoring for non-inferiority trials: minimizing patient exposure to inferior therapies.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Assessing treatment efficacy in the subset of responders in a randomized clinical trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Statistical controversies in clinical research: assessing pathologic complete response as a trial-level surrogate end point for early-stage breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
A new microsimulation model of HPV natural history for comparison of novel cervical screening strategies.
Journal of the National Cancer Institute·2026
Advancing opportunities for collaboration between national cancer Institute-Designated cancer centers and native nations: Building of an indigenous cancer health department.
Journal of the National Cancer Institute·2026
The early-onset pancreatic cancer paradox: a systematic review and meta-analysis.
Journal of the National Cancer Institute·2026
A validated clinical calculator of a brain metastasis risk (BrMR) prediction model in stage I-III breast cancer patients.
Journal of the National Cancer Institute·2026
Clinical and lifetime natural history of oral cancer: implications for screening and surveillance.
Journal of the National Cancer Institute·2026
21-Gene recurrence score assay in pN2-3 Early-Stage breast cancer: a national cancer database study.
Journal of the National Cancer Institute·2026